These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6233749)

  • 21. Down-regulation and redistribution of GPV/GPVf2, a subunit of von Willebrand factor receptor (GPIb/IX/V complex), on the surface membrane of thrombin-stimulated human platelets.
    Kawano H; Suzuki H; Tanoue K; Kimura A; Fujimura K
    Br J Haematol; 1999 Jan; 104(1):55-63. PubMed ID: 10027712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel antithrombotic drugs in development.
    Verstraete M; Zoldhelyi P
    Drugs; 1995 Jun; 49(6):856-84. PubMed ID: 7641602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and characterization of the gene encoding the murine glycoprotein V: the conserved thrombin-cleavable protein on platelet surface.
    Katsutani S; Fujimoto TT; Noda M; Shimomura T; Takafuta T; Kimura A; Fujimura K
    Thromb Res; 1998 Oct; 92(1):43-51. PubMed ID: 9783673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib.
    Huang TF; Chang MC; Teng CM
    Biochim Biophys Acta; 1993 Nov; 1158(3):293-9. PubMed ID: 8251530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The action of calcium-dependent protease on platelet surface glycoproteins.
    McGowan EB; Yeo KT; Detwiler TC
    Arch Biochem Biophys; 1983 Nov; 227(1):287-301. PubMed ID: 6314909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
    Jørgensen KA; Dyerberg J; Stoffersen E
    Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reactions of platelet membrane glycoprotein, glycocalicin, GPI and thrombin].
    Moroi M
    Rinsho Byori; 1982 Jun; Suppl 50():76-83. PubMed ID: 7131809
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
    Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of protease on platelet plasma membrane proteins. The mode of thrombin action on glycoprotein I and V and on platelet functions.
    Fujimura K; Maehama S; Kuramoto A
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1168-77. PubMed ID: 6460411
    [No Abstract]   [Full Text] [Related]  

  • 30. The inhibition of platelet prothrombinase activity by prostacyclin.
    Zwaal RF; Comfurius P; Hemker HC; Bevers EM
    Haemostasis; 1984; 14(4):320-4. PubMed ID: 6094319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin and low molecular weight heparin but not hirudin stimulate platelet aggregation in whole blood from acetylsalicylic acid treated healthy volunteers.
    Chen JH; Karlberg KE; Sylvén C
    Thromb Res; 1991 Aug; 63(3):319-29. PubMed ID: 1659747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin.
    De Candia E; De Cristofaro R; Landolfi R
    Circulation; 1999 Jun; 99(25):3308-14. PubMed ID: 10385507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies against platelet membrane glycoproteins. III. Effect on thrombin-and bovine Von Willebrand factor-induced aggregation.
    Jenkins CS; Clemetson KJ; Ali-Briggs EF
    Br J Haematol; 1983 Mar; 53(3):491-501. PubMed ID: 6600621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM; Buckland RJ; Holgate CE; Storey RF
    Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Receptors on the platelet membrane].
    Watanabe K; Ando Y
    Rinsho Byori; 1985 Jul; 33(7):726-33. PubMed ID: 2999470
    [No Abstract]   [Full Text] [Related]  

  • 39. Biosynthesis of platelet glycoprotein V expressed as a single subunit or in association with GPIb-IX.
    Strassel C; Moog S; Baas MJ; Cazenave JP; Lanza F
    Eur J Biochem; 2004 Sep; 271(18):3671-7. PubMed ID: 15355344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM; Sloane BF; Honn KV
    Thromb Res; 1984 Jun; 34(5):367-78. PubMed ID: 6377570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.